Puylaert Kevin 4

What Happened Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA (SOPH), sold 33 shares on 2026-03-19 at $4.76 per share, generating proceeds of approximately $157. The sale was reported on a Form 4 filed 2026-03-20 and was a disposition (sale) rather than a purchase.

Key Details

• Transaction date: 2026-03-19; filing date: 2026-03-20 (timely filed).
• Sale: 33 shares at $4.76 per share; total proceeds ≈ $157.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: The shares were sold in the open market as a "sell-to-cover" to satisfy tax withholding related to RSUs that vested on 2026-03-18. The sale was not a discretionary trade.
• Transaction code: S (Sale); tax withholding indicated (footnote F1).

Context Sell-to-cover transactions are routine tax-withholding actions when restricted stock units vest and do not necessarily indicate the insider's view on the company's prospects. Purchases generally carry more weight for signaling, while small withholding sales like this are common and procedural.